Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2004 1
2005 2
2007 1
2008 2
2009 5
2011 1
2012 3
2013 3
2014 1
2015 5
2016 5
2017 8
2018 6
2019 2
2020 7
2021 4
2022 4
2023 4
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

57 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean alessandro fabbri (24 results)?
PEOPLE (NTC03447678), a phase II trial to test pembrolizumab as first-line treatment in patients with advanced NSCLC with PD-L1 <50%: a multiomics analysis.
Lo Russo G, Prelaj A, Dolezal J, Beninato T, Agnelli L, Triulzi T, Fabbri A, Lorenzini D, Ferrara R, Brambilla M, Occhipinti M, Mazzeo L, Provenzano L, Spagnoletti A, Viscardi G, Sgambelluri F, Brich S, Miskovic V, Pedrocchi ALG, Trovo' F, Manglaviti S, Giani C, Ambrosini P, Leporati R, Franza A, McCulloch J, Torelli T, Anichini A, Mortarini R, Trinchieri G, Pruneri G, Torri V, De Braud F, Proto C, Ganzinelli M, Garassino MC. Lo Russo G, et al. Among authors: fabbri a. J Immunother Cancer. 2023 Jun;11(6):e006833. doi: 10.1136/jitc-2023-006833. J Immunother Cancer. 2023. PMID: 37286305 Free PMC article. Clinical Trial.
Lung carcinoid tumours: histology and Ki-67, the eternal rivalry.
Centonze G, Maisonneuve P, Simbolo M, Lagano V, Grillo F, Fabbri A, Prinzi N, Garzone G, Filugelli M, Pardo C, Mietta A, Pusceddu S, Sabella G, Bercich L, Mangogna A, Rolli L, Grisanti S, Benvenuti MR, Pastorino U, Roz L, Scarpa A, Berruti A, Capella C, Milione M. Centonze G, et al. Among authors: fabbri a. Histopathology. 2023 Jan;82(2):324-339. doi: 10.1111/his.14819. Epub 2022 Oct 26. Histopathology. 2023. PMID: 36239545 Free PMC article.
Grading lung neuroendocrine tumors: Controversies in search of a solution.
Pelosi G, Pattini L, Morana G, Fabbri A, Faccinetto A, Fazio N, Valeri B, Sonzogni A. Pelosi G, et al. Among authors: fabbri a. Histol Histopathol. 2017 Mar;32(3):223-241. doi: 10.14670/HH-11-822. Epub 2016 Sep 15. Histol Histopathol. 2017. PMID: 27628949 Review.
Characterization of two transcriptomic subtypes of marker-null large cell carcinoma of the lung suggests different origin and potential new therapeutic perspectives.
Simbolo M, Centonze G, Gkountakos A, Monti V, Maisonneuve P, Golovco S, Sabella G, Del Gobbo A, Gobbo S, Ferrero S, Fabbri A, Pardo C, Garzone G, Prinzi N, Pusceddu S, Testi A, Rolli L, Mangogna A, Bercich L, Benvenuti MR, Bria E, Pilotto S, Berruti A, Pastorino U, Capella C, Infante M, Milella M, Scarpa A, Milione M. Simbolo M, et al. Among authors: fabbri a. Virchows Arch. 2024 Jan 3. doi: 10.1007/s00428-023-03721-4. Online ahead of print. Virchows Arch. 2024. PMID: 38168015
Immune-Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer With Uncommon Histology.
Manglaviti S, Brambilla M, Signorelli D, Ferrara R, Lo Russo G, Proto C, Galli G, De Toma A, Occhipinti M, Viscardi G, Beninato T, Zattarin E, Bini M, Lobefaro R, Massa G, Bottiglieri A, Apollonio G, Sottotetti E, Di Mauro RM, Trevisan B, Ganzinelli M, Fabbri A, de Braud FGM, Garassino MC, Prelaj A. Manglaviti S, et al. Among authors: fabbri a. Clin Lung Cancer. 2022 Jan;23(1):e17-e28. doi: 10.1016/j.cllc.2021.06.013. Epub 2021 Jul 5. Clin Lung Cancer. 2022. PMID: 34334296
SMO mutations confer poor prognosis in malignant pleural mesothelioma.
Signorelli D, Proto C, Botta L, Trama A, Tiseo M, Pasello G, Lo Russo G, Fabbri A, Imbimbo M, Busico A, Prelaj A, Ferrara R, Galli G, De Toma A, Tamborini E, Pastorino U, de Braud F, Gatta G, Garassino MC, Ganzinelli M. Signorelli D, et al. Among authors: fabbri a. Transl Lung Cancer Res. 2020 Oct;9(5):1940-1951. doi: 10.21037/tlcr-19-425. Transl Lung Cancer Res. 2020. PMID: 33209614 Free PMC article.
Nutritional parameters associated with prognosis in non-critically ill hospitalized COVID-19 patients: The NUTRI-COVID19 study.
Caccialanza R, Formisano E, Klersy C, Ferretti V, Ferrari A, Demontis S, Mascheroni A, Masi S, Crotti S, Lobascio F, Cerutti N, Orlandoni P, Dalla Costa C, Redaelli E, Fabbri A, Malesci A, Corrao S, Bordandini L, Cereda E; NUTRI-COVID19 Collaborative Working Group. Caccialanza R, et al. Among authors: fabbri a. Clin Nutr. 2022 Dec;41(12):2980-2987. doi: 10.1016/j.clnu.2021.06.020. Epub 2021 Jun 25. Clin Nutr. 2022. PMID: 34353669 Free PMC article.
57 results